A Role for Hepatitis C Virus Infection in Type II Cryoglobulinemia

New England Journal of Medicine

Volumn 327, Issue 21, 1992, Pages 1490-1495

  Agnello, Vincent ^b,c   Chung, Raymond T ^a   Kaplan, Lee M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; CRYOPRECIPITATE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; SERUM; SUPERNATANT; VASCULITIS; VIRION;

EID: 0026439201     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199211193272104     Document Type: Article

References (36)

1. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia — a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837–56.
2. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287–308.
3. Brouet J-C, Clauvel J-P, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775–88.
4. Kunkel HG, Agnello V, Joslin FG, Winchester RJ, Capra JD. Cross-idiotypic specificity among monoclonal IgM proteins with anti-γ-globulin activity. J Exp Med 1973; 137: 331–42.
5. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79–94.
6. Monteverde A, Rivano MT, Allegra GC, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988; 79: 20–5.
7. Realdi G, Alberti A, Rigoli A, Tremolada F. Immune-complexes and Australia antigen in cryoglobulinemic sera. Z Immunitatsforsch 1974; 147: 114–26.
8. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977; 296: 1501–4.
9. Dienstag JL. Hepatitis B as an immune complex disease. Semin Liver Dis 1981; 1: 45–57.
10. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V. HBsAg glomerular deposits in glomerulonephritis: fact or artifact? Kidney Int 1981; 19: 579–86.
11. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381–8.
12. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500.
13. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569–70.
14. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bonomo L. Cryoglobulinaemia and hepatitis C virus. Lancet 1991; 337: 1047–8.
15. Ferri C, Greco F, Longombardo G, et al. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991; 19: 417–20.
16. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621–4.
17. Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606–10.
18. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 754–7.
19. Ikeda Y, Toda G, Hashimoto N, Kurokawa K. Antibody to Superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus. Lancet 1990; 335: 1345–6.
20. Erlich HA, Gelfand D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991; 252: 1643–51.
21. Giusti G, Galanti B, Gaeta GB. Epidemiology of viral hepatitis in Italy. Boll Ist Sieroter Milan 1980; 59: 571–80.
22. Coltorti M, Persico M, Caporaso N. Characteristics of 184 consecutive cases of chronic hepatitis in South-Italy. Presented at the Third International Symposium on HCV, Strasbourg, France, September 16–17, 1991. abstract.
23. Agnello V. Immune complex assays: the first ten years. Ann Intern Med 1981; 94: 266–7.
24. Agnello V, Arbetter A, Ibanez de Kasep G, Powell R, Tan EM, Joslin F. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med 1980; 151: 1514–27.
25. Agnello V, Barnes JL. Human rheumatoid factor crossidiotypes. I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 1986; 164: 1809–14.
26. Chung RT, Dienstag JL, Kaplan LM. Precise quantitation of hepatitis C RNA using a competitive polymerase chain reaction: correlation of clinical course with levels of circulating RNA. Hepatology 1991; 14: Suppl: 65A. abstract.
27. Plagemann PG. Hepatitis C virus. Arch Virol 1991; 120: 165–80.
28. Agnello V, Koffler D, Kunkel HG. Immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int 1973; 3: 90–9.
29. Tanaka M, Kobayashi S, Tajima M, et al. Hepatitis C virus (HCV) antibodies in the rheumatic diseases. Clin Exp Rheumatol 1991; 9: 308–9.
30. Sanz I, Casali P, Thomas JW, Notkins AL, Capra JD. Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol 1989; 142: 4054–61.
31. Barnes JL, Goñi F, Heyermann H, Frangione B, Agnello V. Human rheumatoid factor cross-idiotypes. III. Bla monoclonal rheumatoid factor, prototype of the BLA cross-idiotype group, has distinct kappa chains related to the VκIII subgroup and VH4 heavy chains. Arthritis Rheum 1990; 33: 1710–5.
32. Dighiero G, Lymberi P, Guilbert B, Ternynck T, Avrameas S. Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann N Y Acad Sci 1986; 475: 135–45.
33. Pascual V, Capra JD. VH4–21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis Rheum 1992; 35: 11–8.
34. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987; 83: 726–30.
35. Knox TA, Hillyer CD, Kaplan MM, Berkman EM. Mixed cryoglobulinemia responsive to interferon-α. Am J Med 1991; 91: 554–5.
36. Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha interferon in the treatment of mixed cryoglobulinaemia patients. Eur J Cancer 1991; 27: Suppl 4: S81–S82.